白细胞介素-35通过限制脓毒症中高迁移率族蛋白B1依赖的自噬下调效应CD4+ T细胞的免疫反应
该研究在C57BL/6小鼠中采用盲肠结扎穿刺(CLP)诱导脓毒症,探讨抗炎细胞因子IL-35对效应CD4+ T细胞的作用。结果显示脓毒症小鼠血清和脾脏IL-35水平显著升高;CLP后给予重组IL-35进一步降低效应CD4+ T细胞增殖和Th1/Th2比值,并显著缩短生存时间。脓毒症诱导的自噬激活对效应CD4+ T细胞具有保护作用,而被重组IL-35阻断;体外激活的效应CD4+ T细胞中IL-35抑制自噬的作用由限制高迁移率族蛋白B1(HMGB1)转位介导。作者认为IL-35是脓毒症中损害CD4+ T细胞增殖与分化的免疫抑制性细胞因子,其作用可能通过减少HMGB1依赖的自噬实现。
要点
- 脓毒症小鼠血清和脾脏IL-35水平显著升高。
- CLP后给予重组IL-35进一步降低效应CD4+ T细胞增殖和Th1/Th2比值,并显著缩短生存时间。
- 脓毒症诱导的自噬激活对效应CD4+ T细胞具有保护作用,该自噬被重组IL-35阻断。
- IL-35抑制自噬的作用由限制HMGB1转位介导。
- 作者认为IL-35是损害脓毒症CD4+ T细胞增殖与分化的免疫抑制性细胞因子。
适用人群与场景
- C57BL/6小鼠,采用盲肠结扎穿刺(CLP)诱导脓毒症模型。
处置流程与药物剂量
- CLP后给予重组IL-35(rIL-35);原文未写明剂量、途径和疗程。
- 使用抗IL-35(EBI3)处理;原文未写明剂量、途径和疗程。
研究设计与关键结果
- 研究类型:动物实验(C57BL/6小鼠CLP脓毒症模型)及体外激活效应CD4+ T细胞实验。
- 脓毒症小鼠血清和脾脏IL-35水平显著升高。
- CLP后给予重组IL-35进一步降低效应CD4+ T细胞增殖和Th1/Th2比值,并显著缩短生存时间。
- 脓毒症诱导的自噬激活对效应CD4+ T细胞具有保护作用,并被重组IL-35阻断。
- 体外激活的效应CD4+ T细胞中观察到IL-35抑制自噬,该作用由限制HMGB1转位介导。
证据类型、等级与局限
- 证据类型:动物实验及体外细胞实验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为IL-35是脓毒症中损害CD4+ T细胞增殖与分化的免疫抑制性细胞因子,其作用可能通过减少HMGB1依赖的自噬实现。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background: Immunosuppression is critically involved in the development of sepsis and is closely associated with poor outcomes. The novel role of the anti-inflammatory cytokine IL-35 in sepsis was examined. Methods: Sepsis was induced by in C57BL/6 mice cecal ligation and puncture (CLP). The impacts of IL-35 on effector CD4 + T cells were investigated by examining cell proliferation and the Th1/Th2 ratio in the presence of recombinant IL-35 (rIL-35) or anti-IL-35 (EBI3). The regulatory effect of IL-35 on autophagy was evaluated by measuring autophagy markers and autophagic flux in CLP mice in vivo and in activated effector CD4 + T cells in vitro . Results: IL-35 levels were significantly increased in the serum and spleens of septic mice. rIL-35 administration after CLP further decreased proliferation and the Th1/Th2 ratio in effector CD4 + T cells and significantly shortened the survival time. Sepsis-induced autophagy activation was protective in effector CD4 + T cells and was blocked by rIL-35. The inhibitory effect of IL-35 on autophagy was observed in activated effector CD4 + T cells in vitro , and this effect was mediated by restricting high mobility group box-1 protein (HMGB1) translocation. Conclusion: IL-35 is an immunosuppressive cytokine that impairs CD4 + T-cell proliferation and differentiation in sepsis, and the effect might be mediated by reducing HMGB1-dependent autophagy.
参考来源
- Wu T, Ren C, Dou X, et al. INTERLEUKIN-35 DOWNREGULATES THE IMMUNE RESPONSE OF EFFECTOR CD4 + T CELLS VIA RESTRICTING HIGH MOBILITY GROUP BOX-1 PROTEIN-DEPENDENT AUTOPHAGY IN SEPSIS. Shock. 2022. PMID: 36731088. doi:10.1097/SHK.0000000000001990
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。